{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:56:40Z","timestamp":1792245400513,"version":"4.4.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.prp.2021.153611","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T11:09:25Z","timestamp":1631531365000},"page":"153611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Role of GATA3 in tumor diagnosis: A review"],"prefix":"10.1016","volume":"226","author":[{"given":"Mahdis","family":"Khazaeli Najafabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mirzaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Memar Montazerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Tavangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Tabary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Tavangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2021.153611_bib1","first-page":"406","article-title":"SOX10 and GATA3 in adenoid cystic carcinoma and polymorphous adenocarcinoma","volume":"14","author":"Adkins","year":"2019","journal-title":"Head. Neck\u00a0Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-278","article-title":"Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover","volume":"14","author":"Adomas","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2021.153611_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55382-6","article-title":"Epigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomes","volume":"9","author":"Almutairi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2021.153611_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-020-05818-9","article-title":"Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors","volume":"184","author":"Aphivatanasiri","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2021.153611_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/jcm7090280","article-title":"The diagnosis and clinical significance of paragangliomas in unusual locations","volume":"7","author":"Asa","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2021.153611_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humpath.2015.09.035","article-title":"The role of GATA3 in breast carcinomas: a review","volume":"48","author":"Asch-Kendrick","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","article-title":"Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation","volume":"9","author":"Asselin-Labat","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.prp.2021.153611_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/IJPM.IJPM_651_19","article-title":"GATA3 expression in the solid cell nest of thyroid","volume":"63","author":"Ayyanar","year":"2020","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.prp.2021.153611_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PAS.0000000000000315","article-title":"GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility","volume":"39","author":"Banet","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/PAS.0000000000000825","article-title":"GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung","volume":"41","author":"Berg","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib11","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.humpath.2014.04.011","article-title":"GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin","volume":"45","author":"Bezerra","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dc.23206","article-title":"Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens","volume":"43","author":"Braxton","year":"2015","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2021.153611_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/his.13187","article-title":"GATA3 expression in triple\u2010negative breast cancers","volume":"71","author":"Byrne","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153611_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.prp.2016.12.010","article-title":"GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas","volume":"213","author":"Cakir","year":"2017","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2021.153611_bib15","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1002\/ijc.31750","article-title":"GATA3 as a master regulator and therapeutic target in ovarian high\u2010grade serous carcinoma stem cells","volume":"143","author":"Chen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2021.153611_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcp.21943","article-title":"GATA3 in development and cancer differentiation: cells GATA have it!","volume":"222","author":"Chou","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2021.153611_bib17","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/onc.2011.382","article-title":"GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells","volume":"31","author":"Chu","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2021.153611_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1309\/AJCP8H2VBDSCIOBF","article-title":"Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7\u2013positive carcinomas","volume":"142","author":"Clark","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib19","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/onc.2010.64","article-title":"Loss of type III transforming growth factor-\u03b2 receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma","volume":"29","author":"Cooper","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2021.153611_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80770-9","article-title":"Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient\u2013induced determination of pituitary cell types","volume":"97","author":"Dasen","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.prp.2021.153611_bib21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000000505","article-title":"GATA3 immunohistochemistry expression in histologic subtypes of primary breast carcinoma and metastatic breast carcinoma cytology","volume":"39","author":"Deftereos","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/med.21362","article-title":"The significance and therapeutic potential of GATA3 expression and mutation in breast cancer: a systematic review","volume":"35","author":"Du","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.prp.2021.153611_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jasc.2015.01.008","article-title":"Utility of GATA3, mammaglobin, GCDFP-15, and ER in the detection of intrathoracic metastatic breast carcinoma","volume":"4","author":"Dyhdalo","year":"2015","journal-title":"J. Am. Soc. Cytopathol."},{"key":"10.1016\/j.prp.2021.153611_bib24","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1158\/0008-5472.CAN-07-0746","article-title":"Positive cross-regulatory loop ties GATA-3 to estrogen receptor \u03b1 expression in breast cancer","volume":"67","author":"Eeckhoute","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2021.153611_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109539","article-title":"GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma","volume":"68","author":"El-Arabey","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prp.2021.153611_bib26","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.21873\/anticanres.12745","article-title":"Mutant GATA3 actively promotes the growth of normal and malignant mammary cells","volume":"38","author":"Emmanuel","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2021.153611_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jss.2008.07.015","article-title":"GATA-3 as a marker of hormone response in breast cancer","volume":"157","author":"Fang","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prp.2021.153611_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.humpath.2018.06.004","article-title":"The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer","volume":"80","author":"Fararjeh","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.humpath.2014.03.015","article-title":"GATA3 expression in sarcomatoid urothelial carcinoma of the bladder","volume":"45","author":"Fatima","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/cdd.2017.10","article-title":"Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium","volume":"24","author":"Fishwick","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2021.153611_bib31","first-page":"1749","article-title":"Santo, GATA-3 promotes T-cell specification by repressing B-cell potential in pro\u2013T cells in mice","volume":"121","author":"Garc\u00eda-Ojeda","year":"2013","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.prp.2021.153611_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.humpath.2013.08.020","article-title":"Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms","volume":"45","author":"Gonzalez-Roibon","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41379-018-0021-y","article-title":"Differential expression patterns of GATA3 in usual and differentiated types of vulvar intraepithelial neoplasia: potential diagnostic implications","volume":"31","author":"Goyal","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib34","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI42021","article-title":"Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2","volume":"120","author":"Grigorieva","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2021.153611_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1242\/dev.02184","article-title":"Pax2\/8-regulated Gata3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney","volume":"133","author":"Grote","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.prp.2021.153611_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12022-017-9511-6","article-title":"Positivity for GATA3 and TTF-1 (SPT24), and negativity for monoclonal PAX8 expand the biomarker profile of the solid cell nests of the thyroid gland","volume":"29","author":"Gucer","year":"2018","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib37","doi-asserted-by":"crossref","first-page":"103415","DOI":"10.18632\/oncotarget.21910","article-title":"GATA3 frameshift mutation promotes tumor growth in human luminal breast cancer cells and induces transcriptional changes seen in primary GATA3 mutant breast cancers","volume":"8","author":"Gustin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2021.153611_bib38","first-page":"143","article-title":"Can GATA3 immunocytochemistry be utilized as a reliable diagnostic marker for metastatic breast carcinoma in cytological materials? A comparative study with mammaglobin and GCDFP-15 expression","volume":"34","author":"Hafez","year":"2018","journal-title":"Turk. J. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156524","article-title":"GATA3 expression is a poor prognostic factor in soft tissue sarcomas","volume":"11","author":"Haraguchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2021.153611_bib40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/PAI.0000000000000143","article-title":"Uroplakin II (UPII), GATA3, and p40 are highly sensitive markers for the differential diagnosis of invasive urothelial carcinoma","volume":"23","author":"Hoang","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2021.153611_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-014-2867-0","article-title":"Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre-and postmenopausal women with estrogen receptor-positive breast cancer","volume":"144","author":"Hosoda","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2021.153611_bib42","doi-asserted-by":"crossref","first-page":"36040","DOI":"10.18632\/oncotarget.16424","article-title":"Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia","volume":"8","author":"Hou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2021.153611_bib43","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.humpath.2017.04.003","article-title":"GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator","volume":"64","author":"Inoue","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2249","article-title":"Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer","volume":"11","author":"Jacquemier","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2021.153611_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/cncr.28566","article-title":"GATA3 mutations define a unique subtype of luminal\u2010like breast cancer with improved survival","volume":"120","author":"Jiang","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2021.153611_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/01478885.2019.1667126","article-title":"Reduced expression of GATA3 predicts progression in non\u2013muscle invasive urothelial carcinoma of the urinary bladder","volume":"43","author":"Kamel","year":"2020","journal-title":"J. Histotechnol."},{"key":"10.1016\/j.prp.2021.153611_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mpdhp.2018.12.004","article-title":"Gestational trophoblastic tumours and non-neoplastic trophoblastic lesions: morphology and immunocytochemistry to refine the diagnosis","volume":"25","author":"Kaur","year":"2019","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.prp.2021.153611_bib49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PAI.0000000000000581","article-title":"GATA3 Immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities","volume":"27","author":"Kezlarian","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2021.153611_bib50","first-page":"175","article-title":"The potential of circulating tumor cells in personalized management of breast cancer: a systematic review","volume":"55","author":"Khatami","year":"2017","journal-title":"Acta Med. Iran."},{"key":"10.1016\/j.prp.2021.153611_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184892","article-title":"Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer","volume":"12","author":"Khatami","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2021.153611_bib52","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2147\/CMAR.S188661","article-title":"Oncometabolites as biomarkers in thyroid cancer: a systematic review","volume":"11","author":"Khatami","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2021.153611_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.30699\/ijp.2017.26267","article-title":"Current diagnostic status of pheochromocytomaand future perspective: A mini review","volume":"12","author":"Khatami","year":"2017","journal-title":"Iran. J. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib54","first-page":"235","article-title":"Liquid biopsy in thyroid cancer: new insight","volume":"12","author":"Khatami","year":"2018","journal-title":"Int. J. Hematol. -Oncol. Stem Cell Res."},{"key":"10.1016\/j.prp.2021.153611_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.30699\/ijp.13.2.125","article-title":"A review of driver genetic alterations in thyroid cancers","volume":"13","author":"Khatami","year":"2018","journal-title":"Iran. J. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib56","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2016.04.013","article-title":"Expression patterns of GATA3 and the androgen receptor are strongly correlated in patients with triple-negative breast cancer","volume":"55","author":"Kim","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12022-020-09618-1","article-title":"The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma","volume":"31","author":"Kimura","year":"2020","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cncy.21952","article-title":"GATA 3 differential expression in neuroblastoma and nephroblastoma","volume":"126","author":"Klijanienko","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.prp.2021.153611_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.prp.2021.153611_bib60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ceb.2008.02.003","article-title":"GATA-3 and the regulation of the mammary luminal cell fate","volume":"20","author":"Kouros-Mehr","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.prp.2021.153611_bib61","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","article-title":"GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland","volume":"127","author":"Kouros-Mehr","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.prp.2021.153611_bib62","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.humpath.2014.06.022","article-title":"Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer","volume":"45","author":"Krings","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib63","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.pathol.2016.05.008","article-title":"A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma","volume":"48","author":"Leivo","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.prp.2021.153611_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/erm.2016.2","article-title":"The emerging role of GATA transcription factors in development and disease","volume":"18","author":"Lentjes","year":"2016","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.prp.2021.153611_bib65","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cncy.21574","article-title":"Young investigator challenge: the utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions","volume":"123","author":"Lew","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.prp.2021.153611_bib66","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4161\/cbt.27631","article-title":"Loss of GATA3 in bladder cancer promotes cell migration and invasion","volume":"15","author":"Li","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2021.153611_bib67","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.humpath.2014.02.023","article-title":"Differential expression of GATA-3 in urothelial carcinoma variants","volume":"45","author":"Liang","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/76080","article-title":"Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system","volume":"25","author":"Lim","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2021.153611_bib69","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1309\/AJCP0Q9UQTEESLHN","article-title":"Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas","volume":"141","author":"Liu","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s002399910012","article-title":"Molecular evolution of the GATA family of transcription factors: conservation within the DNA-binding domain","volume":"50","author":"Lowry","year":"2000","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.prp.2021.153611_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6295-8","article-title":"Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance","volume":"19","author":"Lu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2021.153611_bib73","first-page":"72","article-title":"Non-functioning pituitary adenoma: immunohistochemical analysis of 85 cases","volume":"45","author":"Mahta","year":"2007","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.prp.2021.153611_bib74","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3324\/haematol.2016.143768","article-title":"C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas","volume":"101","author":"Manso","year":"2016","journal-title":"haematologica"},{"key":"10.1016\/j.prp.2021.153611_bib75","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2017.06.016","article-title":"GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics","volume":"66","author":"Mantilla","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib76","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1309\/AJCP5MMR1FJVVTPK","article-title":"GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse","volume":"144","author":"McCleskey","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib77","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1158\/0008-5472.CAN-05-2495","article-title":"Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis","volume":"65","author":"Mehra","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2021.153611_bib78","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/DAD.0000000000000306","article-title":"GATA3 expression in normal skin and in benign and malignant epidermal and cutaneous adnexal neoplasms","volume":"37","author":"Mertens","year":"2015","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.prp.2021.153611_bib79","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","article-title":"GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors","volume":"32","author":"Mete","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib81","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/his.12681","article-title":"GATA 3 expression in gestational trophoblastic tissues and tumours","volume":"67","author":"Mirkovic","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153611_bib82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/his.12625","article-title":"GATA\u2010binding protein 3, gross cystic disease fluid protein\u201015 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups","volume":"67","author":"Ni","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153611_bib83","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAP.0b013e3182a28a68","article-title":"Value of GATA3 immunostaining in tumor diagnosis: a review","volume":"20","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib84","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.humpath.2014.03.006","article-title":"Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study","volume":"45","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2015.09.028","article-title":"The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases","volume":"48","author":"Osman","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib86","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.humpath.2014.02.024","article-title":"Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder","volume":"45","author":"Paner","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib87","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/DAD.0000000000000634","article-title":"GATA3 and MYB expression in cutaneous adnexal neoplasms","volume":"39","author":"Pardal","year":"2017","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.prp.2021.153611_bib88","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0959-437X(02)00319-2","article-title":"The GATA family (vertebrates and invertebrates)","volume":"12","author":"Patient","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.prp.2021.153611_bib89","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/his.13229","article-title":"Utility of GATA 3 in the differential diagnosis of pheochromocytoma","volume":"71","author":"Perrino","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153611_bib90","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.08.005","article-title":"The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas","volume":"105","author":"Prabhakaran","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib92","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","article-title":"Molecular characterization of basal-like and non-basal-like triple-negative breast cancer","volume":"18","author":"Prat","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2021.153611_bib93","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1242\/dev.038828","article-title":"Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2","volume":"137","author":"Ralston","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.prp.2021.153611_bib94","doi-asserted-by":"crossref","first-page":"A093","DOI":"10.1093\/ajcp\/144.suppl2.093","article-title":"Expression of GATA-3 in Benign Mesothelial Cells","volume":"144","author":"Ramirez","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib95","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PGP.0000000000000167","article-title":"Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions","volume":"34","author":"Roma","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib96","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1309\/AJCPI8AJLUZ3CZLN","article-title":"Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma","volume":"135","author":"Saffar","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib97","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","article-title":"Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia","volume":"22","author":"Sanda","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2021.153611_bib98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PAI.0000000000000186","article-title":"The novel marker GATA3 is significantly more sensitive than traditional markers mammaglobin and GCDFP15 for identifying breast cancer in surgical and cytology specimens of metastatic and matched primary tumors","volume":"24","author":"Sangoi","year":"2016","journal-title":"Appl. Immunohistochem. Mol. Morphol.: AIMM"},{"key":"10.1016\/j.prp.2021.153611_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-4-41","article-title":"Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium","volume":"4","author":"Sarmadi","year":"2009","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/his.12776","article-title":"GATA binding protein 3 expression is present in primitive patterns of yolk sac tumours but is not expressed by differentiated variants","volume":"68","author":"Schuldt","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153611_bib101","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12105-013-0442-3","article-title":"GATA3 immunohistochemical expression in salivary gland neoplasms","volume":"7","author":"Schwartz","year":"2013","journal-title":"Head. Neck Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib102","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0560.2009.01416.x","article-title":"Expression pattern of GATA\u20103 in embryonic and fetal human skin suggests a role in epidermal and follicular morphogenesis","volume":"37","author":"Sellheyer","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib103","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/jclinpath-2016-204137","article-title":"Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes","volume":"70","author":"Shaoxian","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib104","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncy.21393","article-title":"GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens","volume":"122","author":"Shield","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.prp.2021.153611_bib105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccell.2015.04.011","article-title":"Dysfunction of the reciprocal feedback loop between GATA3-and ZEB2-nucleated repression programs contributes to breast cancer metastasis","volume":"27","author":"Si","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2021.153611_bib106","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/dc.23131","article-title":"GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: a review of 25 cases","volume":"42","author":"Siddiqui","year":"2014","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2021.153611_bib107","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1507\/endocrj.EJ15-0700","article-title":"Diagnostic value of GATA-3 in cytological identification of parathyroid tissues","volume":"63","author":"Takada","year":"2016","journal-title":"Endocr. J."},{"key":"10.1016\/j.prp.2021.153611_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3727\/105221615X14399878166113","article-title":"GATA3 in breast cancer: tumor suppressor or oncogene?","volume":"16","author":"Takaku","year":"2015","journal-title":"Gene Expr. J. Liver Res."},{"key":"10.1016\/j.prp.2021.153611_bib109","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.prp.2010.01.007","article-title":"Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma","volume":"206","author":"Tavangar","year":"2010","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2021.153611_bib110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1101\/gr.139469.112","article-title":"GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility","volume":"23","author":"Theodorou","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.prp.2021.153611_bib111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.humpath.2014.09.007","article-title":"Utility of uroplakin II expression as a marker of urothelial carcinoma","volume":"46","author":"Tian","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib112","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2014.06.006","article-title":"GATA-3 function in innate and adaptive immunity","volume":"41","author":"Tindemans","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2021.153611_bib113","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/384474a0","article-title":"Transcription factor GATA-3 is required for development of the T-cell lineage","volume":"384","author":"Ting","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.prp.2021.153611_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cup.13037","article-title":"Evaluation and comparison of staining patterns of factor XIIIa (AC\u20101A1), adipophilin and GATA3 in sebaceous neoplasia","volume":"45","author":"Tjarks","year":"2018","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib115","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/annonc\/mds120","article-title":"Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy","volume":"23","author":"Tominaga","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2021.153611_bib116","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.humpath.2018.10.009","article-title":"Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases","volume":"84","author":"Vidarsdottir","year":"2019","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib117","first-page":"365","article-title":"GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiology and Prevention","volume":"17","author":"Voduc","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.prp.2021.153611_bib118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.it.2014.04.002","article-title":"GATA3: a master of many trades in immune regulation","volume":"35","author":"Wan","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.prp.2021.153611_bib119","article-title":"Biological significance of GATA3, cytokeratin 20, cytokeratin 5\/6 and p53 expression in muscle-invasive bladder cancer","volume":"14","author":"Wang","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2021.153611_bib120","first-page":"3007","article-title":"GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features","volume":"123","author":"Wang","year":"2014","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.prp.2021.153611_bib121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.anndiagpath.2014.12.001","article-title":"GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin","volume":"19","author":"Wendroth","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib122","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/intimm\/dxr029","article-title":"An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation","volume":"23","author":"Yagi","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.prp.2021.153611_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.09.011","article-title":"GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors","volume":"26","author":"Yang","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib124","article-title":"The multi-faceted role of Gata3 in developmental haematopoiesis. Royal Society Open","volume":"8","author":"Zaidan","year":"2018","journal-title":"Biology"},{"key":"10.1016\/j.prp.2021.153611_bib125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.prp.2021.153611_bib126","doi-asserted-by":"crossref","first-page":"65284","DOI":"10.18632\/oncotarget.11673","article-title":"GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2021.153611_bib127","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1097\/PAS.0b013e31829e2525","article-title":"Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas","volume":"37","author":"Zhao","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib128","first-page":"3613","article-title":"Simultaneous expression of TTF1 and GATA3 in a lung biopsy sample: confusion in diagnostic pathology","volume":"12","author":"Zhao","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-017-0638-z","article-title":"GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15","volume":"12","author":"Zhao","year":"2017","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2021.153611_bib130","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/1947601911404223","article-title":"GATA transcription factors and cancer","volume":"1","author":"Zheng","year":"2010","journal-title":"Genes Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:48:50Z","timestamp":1759733330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":130,"alternative-id":["S0344033821002727"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153611","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of GATA3 in tumor diagnosis: A review","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153611"}}